Pharmaceutical intermediates Clofarabine raw powder
Pharmaceutical intermediates Clofarabine raw powder
factory
certificate
Home > Pharmaceutical intermediates

Pharmaceutical intermediates Clofarabine raw powder

Related Attributes


Product details

Clofarabine Usage and Synthesis.

clofarabine, also known as clofarabine, is a new purine nucleoside anticancer drug, successfully developed by GenzymeCorporation (GenzymeCorporation, NASDAQ:GENZ), a top ten biopharmaceutical company in the United States, and its trade name is Clofarabine. On December 28, 2004, the United States Food and Drug Administration (FDA) approved clofarabine for the treatment of intractable or recurrent acute lymphoblastic leukemia in children through the fast track, which is the only drug that can be used specifically for the treatment of acute myeloid leukemia (ALL) in children. The treatment of leukemia is highly effective and well tolerated, with no unpredictable adverse reactions. It can be administered intravenously or orally, making it the first new leukemia treatment approved specifically for children in more than a decade.

Clofarabine powder.

Uses of Clofarabine.

Clofarabine

Pharmacological action of Clofarabine.

Clorabine combines the advantages of Fludarabine and Cladribine to inhibit both DNA polymerase and ribonucleic acid reductase. It showed strong anticancer activity against different cell lines and tumor models. Early studies have shown that the concentration of this product below micromole can effectively inhibit the proliferation of human CNS tumors, lung cancer, kidney cancer, leukemia cells and melanoma cell lines. In vivo and in vitro experiments have shown that Crorolabine has apoptotic effect on leukemia cells. This effect is achieved by down-regulating the dephosphorization of BCL-2 group proteins BCL-X and MCL-1 and AKT. Its inhibitory effect on human leukemia cells K-562 was stronger than that of latabine and fludatrebine, with IC50 of 5nmol/L, while the IC50 of clatrebine was 16nmol/L and that of Fludatrebine was 460nmol/L. Preclinical and combination trials have shown that clofarabine and other deoxynucleotide analogues, as well as other types of anticancer agents such as etoposide, can increase the activity of deoxycytidine kinase in normal or abnormal human lymphocytes and therefore increase the anticancer efficacy.

Product Method of Bulk Clofarabine.


Why choose us?

factory

HRK Factory

HRK Factory

About Shipping

shipping

Prev: Natural Ropivacaine hydrochloride raw Materials Powder Next: Raw Materials powder Strontium ranelate

Pharmaceutical Intermediate manufacturers

sales18@interlgroup.com

©2022 Xi'an Henrikang Biotech Co., Ltd.,

HomeHome
EmailE-mail
ProductBooking